GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Everest Organics Ltd (BOM:524790) » Definitions » Beneish M-Score

Everest Organics (BOM:524790) Beneish M-Score : -2.80 (As of Apr. 03, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Everest Organics Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.8 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Everest Organics's Beneish M-Score or its related term are showing as below:

BOM:524790' s Beneish M-Score Range Over the Past 10 Years
Min: -2.8   Med: -2.57   Max: -1.81
Current: -2.8

During the past 9 years, the highest Beneish M-Score of Everest Organics was -1.81. The lowest was -2.80. And the median was -2.57.


Everest Organics Beneish M-Score Historical Data

The historical data trend for Everest Organics's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Everest Organics Beneish M-Score Chart

Everest Organics Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -2.57 -1.81 -2.23 -2.60 -2.80

Everest Organics Quarterly Data
Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.80 - - -

Competitive Comparison of Everest Organics's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Everest Organics's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Everest Organics's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Everest Organics's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Everest Organics's Beneish M-Score falls into.


;
;

Everest Organics Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Everest Organics for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1915+0.528 * 0.7315+0.404 * 0.8337+0.892 * 1.0775+0.115 * 0.8739
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9509+4.679 * -0.07181-0.327 * 1.0381
=-2.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ₹1,019 Mil.
Revenue was ₹1,972 Mil.
Gross Profit was ₹426 Mil.
Total Current Assets was ₹1,500 Mil.
Total Assets was ₹2,267 Mil.
Property, Plant and Equipment(Net PPE) was ₹717 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹58 Mil.
Selling, General, & Admin. Expense(SGA) was ₹111 Mil.
Total Current Liabilities was ₹1,601 Mil.
Long-Term Debt & Capital Lease Obligation was ₹146 Mil.
Net Income was ₹1 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹164 Mil.
Total Receivables was ₹794 Mil.
Revenue was ₹1,830 Mil.
Gross Profit was ₹289 Mil.
Total Current Assets was ₹1,325 Mil.
Total Assets was ₹2,018 Mil.
Property, Plant and Equipment(Net PPE) was ₹640 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹45 Mil.
Selling, General, & Admin. Expense(SGA) was ₹109 Mil.
Total Current Liabilities was ₹1,376 Mil.
Long-Term Debt & Capital Lease Obligation was ₹123 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1019.307 / 1972.412) / (793.952 / 1830.485)
=0.516782 / 0.433739
=1.1915

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(289.311 / 1830.485) / (426.165 / 1972.412)
=0.158052 / 0.216063
=0.7315

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1499.841 + 716.748) / 2267.233) / (1 - (1324.833 + 639.579) / 2018.493)
=0.022337 / 0.026793
=0.8337

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1972.412 / 1830.485
=1.0775

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(44.74 / (44.74 + 639.579)) / (57.958 / (57.958 + 716.748))
=0.065379 / 0.074813
=0.8739

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(111.414 / 1972.412) / (108.735 / 1830.485)
=0.056486 / 0.059402
=0.9509

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((146.431 + 1601.012) / 2267.233) / ((122.752 + 1375.823) / 2018.493)
=0.770738 / 0.742423
=1.0381

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1.392 - 0 - 164.201) / 2267.233
=-0.07181

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Everest Organics has a M-score of -2.80 suggests that the company is unlikely to be a manipulator.


Everest Organics Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Everest Organics's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Everest Organics Business Description

Traded in Other Exchanges
N/A
Address
Opposite Madhapur Police Station Road, 1st Floor, Amar Co-Operative Society, Lakeview Plaza, Plot No. 127 and 128, Near Durgam Cheruvu, Madhapur, Hyderabad, TG, IND, 500 033
Everest Organics Ltd is a pharmaceutical company. It is focused on manufacturing active pharmaceutical ingredients and intermediaries. The products offered by the company include Omeprazole, Ciprofloxacin, Dichloroflurobenzene, Naproxen, Benzimadizole, and others. The company operates in one primary business segment namely Active Pharmaceutical Ingredients (API) and their intermediaries. Geographically, it derives a majority of its revenue from India.

Everest Organics Headlines

No Headlines